Cardiac sarcoidosis presenting as constrictive pericarditis.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4060344)

Published in Tex Heart Inst J on June 01, 2014

Authors

Saba Darda1, Marcel E Zughaib1, Patrick B Alexander1, Christian E Machado1, Shukri W David1, Souheil Saba1

Author Affiliations

1: Department of Cardiology, Providence Hospital and Medical Center, South-field, Michigan 48075.

Articles cited by this

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation (2008) 8.94

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation (2009) 8.93

Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation (1978) 4.45

Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med (1977) 4.34

Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol (2004) 3.50

Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation (1999) 3.25

Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol (2005) 2.93

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol (2007) 2.82

The etiologic spectrum of constrictive pericarditis. Am Heart J (1987) 2.34

Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol (2001) 2.03

Cardiac sarcoidosis. Am Heart J (2008) 1.89

Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) (2004) 1.68

Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol (2005) 1.37

Cardiac sarcoidosis. Heart (2006) 1.34

Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol (2005) 1.31

Sarcoid heart disease. J R Coll Physicians Lond (1981) 1.24

Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn (1993) 1.23

Aetiology of chronic constrictive pericarditis. Br Heart J (1983) 1.08

Constrictive pericarditis in rheumatoid arthritis. Ann Rheum Dis (1986) 1.02

Cardiac sarcoid: a clinician's review on how to approach the patient with cardiac sarcoid. Clin Cardiol (2012) 0.97

Constrictive pericarditis versus restrictive cardiomyopathy: challenges in diagnosis and management. Cardiol Rev (2004) 0.95

Constrictive pericarditis associated with sarcoidosis. Am Heart J (1984) 0.82

Pericardial effusions in sarcoidosis. Chest (1979) 0.79

Pericardial tamponade in sarcoidosis. Can J Cardiol (1987) 0.77